These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9208340)

  • 1. Use of flurythromycin ethylsuccinate in infections of lower airways due to sensitive germs: multicenter comparative study with clarithromycin.
    Vagliasindi M
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):245-9. PubMed ID: 9208340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections].
    Bertrand A; Jonquet O; Sauvaget J
    Pathol Biol (Paris); 1988 May; 36(5):544-7. PubMed ID: 3043354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P; Dobryniewska M; Busman T; Notario G
    Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral therapy with flurithromycin in ear, nose and throat infections.
    Galioto GB; Passali D; Catalano GB; Mevio E; Lepore AM; Romoli L
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):204-7. PubMed ID: 7620689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clarithromycin in the treatment of bacterial relapses of chronic bronchitis.
    Dericoloso A; Sanduzzi A; Cuccurullo S; Sarno M; Bianco A; Moro RA
    Riv Eur Sci Med Farmacol; 1991; 13(5-6):275-83. PubMed ID: 1840282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Notario G; Spiller J; Palmer R; Busman T
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meta-analysis of clarithromycin compared to other antibiotics for the treatment of lower respiratory tract infections].
    Gálvez-Múgica MA; Espinosa de los Monteros MJ; Gallego Sandín S; Novalbos J; Abad-Santos F
    Rev Esp Quimioter; 2003 Dec; 16(4):403-11. PubMed ID: 14961134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic therapy of bacterial respiratory tract infections].
    Schauer J
    Z Gesamte Inn Med; 1992 Sep; 47(9):398-403. PubMed ID: 1441667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
    Neu HC; Chick TW
    Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of Clarithromycin in the treatment of acute mild to moderate respiratory tract infections.
    O'Neill SJ; Millar ED; Coles SJ; Bachand RT
    Ir Med J; 1991 Mar; 84(1):33-5. PubMed ID: 1828461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ribostamycin in chronic and recurrent bronchopulmonary and urinary infections].
    Abate G; Polimeni RM; Visani G
    Minerva Med; 1980 Feb; 71(4):279-85. PubMed ID: 7354947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection.
    Adam D; Glaser-Caldow E; Wachter J; Brueckner OJ; Hein J; Kroemer B; Hirsch J
    Clin Ther; 2001 Apr; 23(4):585-95. PubMed ID: 11354392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia.
    Wiesner B; Wilen-Rosenqvist G; Lehtonen L
    Arzneimittelforschung; 1993 Sep; 43(9):1014-7. PubMed ID: 8240450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections.
    Rocha RT; Awad CE; Ali A; Matyas R; Vital AC; Silva CO; Dainesi SM; Salazar MS; Nakatani J
    Int J Clin Pract; 1999 Sep; 53(6):433-6. PubMed ID: 10622070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new macrolactones: clarithromycin (Biaxin) and azithromycin (Zithromax).
    Peltier K
    Conn Med; 1992 Jul; 56(7):371-4. PubMed ID: 1330429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled study comparing the effect of azithromycin with clarithromycin on oropharyngeal and bowel microflora in volunteers.
    Matute AJ; Schurink CA; Krijnen RM; Florijn A; Rozenberg-Arska M; Hoepelman IM
    Eur J Clin Microbiol Infect Dis; 2002 Jun; 21(6):427-31. PubMed ID: 12111597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clarithromycin in 2003: sustained efficacy and safety in an era of rising antibiotic resistance.
    Anzueto A; Norris S
    Int J Antimicrob Agents; 2004 Jul; 24(1):1-17. PubMed ID: 15225854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacteriological examination of the sputum in support of a rational antibiotic therapy of bronchopulmonary infections].
    Buiuc D; Burcoveanu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(2):159-66. PubMed ID: 6294808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of bacterial infections of the lower respiratory tract. Comparative study: Tibirox versus erythromycin].
    Petite J
    Schweiz Rundsch Med Prax; 1982 Nov; 71(47):1860-5. PubMed ID: 6760172
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
    Hoban DJ; Zhanel GG
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.